Give a detailed notes easy to understand and remember on a flow and add additional detail for understanding. Use this lecture notes
cd /tmp/workspace/attachments/6d777fb2-3783-43b1-8f92-0a79a5cb9274 && python3 -c " from pptx import Presentation prs = Presentation('Infective Endocarditis.pptx') for i, slide in enumerate(prs.slides, 1): print(f'\n=== SLIDE {i} ===') for shape in slide.shapes: if shape.has_text_frame and shape.text_frame.text.strip(): print(shape.text_frame.text) "
infective endocarditis vegetation cardiac valve pathology
Histology of a cardiac valve vegetation from an intravenous drug user with infective endocarditis. The specimen was processed for light microscopy and stained with hematoxylin and eosin (H&E). The vegetative mass adheres to the valvular surface and shows a dominant thrombus composed of densely packed fibrin and platelets, with admixed bacterial colonies appearing as dark purple clusters within the eosinophilic matrix. The core is friable and irregular, with a leafy, chain-like fringe along the valve edge. The bacterial colonies are variably distributed, forming focal microcolonies that disrupt surrounding tissue architecture. There is limited or variable inflammatory cell infiltrate; neutrophils may be present at the margins, consistent with acute infective endocarditis. The overall pattern is consistent with septic endocarditis in an intravenous drug user, where bacteria colonize a pre-existing thrombus on the valve surface, producing vegetations that may embolize. Clinically, histology complements microbiology and imaging to confirm diagnosis and guide antibiotic therapy. Diagnostic significance includes identification of infectious vegetations on valves, distinguishing from sterile thrombi, and informing prognosis. Potential differential diagnoses include nonbacterial thrombotic endocarditis and Libman-Sacks endocarditis in alternative clinical settings. This image is valuable for education on endocarditis pathology, valve destruction, and the histopathology of septic vegetations.
Infective endocarditis histology image demonstrating a valve leaflet vegetation attached to the endocardial surface. The lesion is a friable thrombus-rich mass composed predominantly of fibrin and platelets with an inflammatory cell infiltrate. Bacterial colonies are not evident on routine hematoxylin and eosin staining, which can occur in culture-negative endocarditis or after prior antibiotic exposure; additional stains or culture may reveal organisms. The vegetation is anchored to the valve leaflet, illustrating the pathological substrate of infection and its interface with native tissue. This pattern supports a diagnosis of infective endocarditis in the clinical context and helps distinguish from noninfectious vegetations such as marantic endocarditis or Libman-Sacks endocarditis. Clinically, the histology guides antimicrobial strategy, duration, and need for surgical evaluation, given the embolic potential of friable vegetations. Educationally, this image is valuable for cardiac pathology and infectious disease training, highlighting thrombus-dominated composition, inflammatory infiltration, and the frequent absence of visible bacteria on standard histology.
Gross pathology photograph of an explanted heart demonstrating left-sided infective endocarditis with mitral valve involvement. The image highlights a shaggy vegetative mass on the mitral valve, with thickened chordae tendineae and irregular nodularity of the cusp just to the right of the vegetation. The vegetations are friable and tan-pink, with adjacent valvular tissue showing edema and thickening. The chords appear markedly elongated and edematous, consistent with valvular destruction and tethering. The cusp shows focal thickening and rime-like nodules indicative of inflammatory deposition and possible microabscess formation. This gross morphology correlates with acute/subacute infective endocarditis, often due to bacterial pathogens such as Staphylococcus aureus or viridans streptococci, though fungal infections can also be implicated. Clinically, such findings signal bacteremia, embolic risk, and potential heart failure from valvular insufficiency. The image is valuable for education in cardiac pathology, surgical pathology, and infectious disease teaching; it demonstrates typical mitral valve vegetations, chordal involvement, and cusp irregularity useful for differential diagnosis with Libman-Sacks endocarditis, rheumatic disease, or marantic endocarditis. In practice, correlation with blood cultures, echocardiography, and systemic evaluation is essential for diagnosis and management. Documentation of vegetative morphology aids correlating radiographic and microbiological findings, informs prognosis, and guides rheology of therapeutic interventions management.
🫀 INFECTIVE ENDOCARDITIS (IE) - Complete Notes
1. WHAT IS IT? (Definition)
Think of it this way: Bugs enter the bloodstream → stick to a damaged valve → form a clump (vegetation) → this clump can break off and travel anywhere in the body.
- Heart valves (most common) - mitral, aortic, pulmonary, septal valves
- Prosthetic valves
- Sometimes the wall of the cardiac chamber itself
2. THE FLOW: HOW DOES IE DEVELOP?
PREDISPOSING FACTOR (damaged valve / IV drug use)
↓
BACTERAEMIA (bacteria enter the blood)
- Dental procedures, surgery, GI/GU manipulation,
IV drug injection, intravascular catheters
↓
BACTERIA SEED A VALVE
- Damaged endothelium → sterile platelet-fibrin clot forms
- Bacteria stick to this clot
↓
VEGETATION FORMS
(fibrin + platelets + bacteria = friable clump on valve)
↓
THREE PATHWAYS OF DAMAGE:
1. Local destruction (valve rupture, myocardial abscess)
2. Embolization (vegetations break off → travel to brain, kidneys, skin)
3. Immune complex deposition (circulating immune complexes → Osler's nodes, Roth spots)
3. PREDISPOSING FACTORS (Who is at risk?)
| Risk Factor | Why It Matters |
|---|---|
| Rheumatic valvular disease | Scarred, irregular valve surface - bacteria can easily stick |
| Congenital heart disease (VSD, PDA) | Turbulent blood flow damages endothelium |
| Prosthetic valve surgery | Foreign material = easy bacterial colonization |
| Intravenous drug use (IDU) | Direct injection of bacteria into bloodstream; often affects right-sided valves (tricuspid) |
| Degenerative cardiac diseases | Calcium deposits on valves create rough surfaces |
| PPM (Pacemaker), Central catheters, Dialysis shunts | Lines provide a physical path for bacteria to reach the heart |
Memory tip: "RCP-IDD" - Rheumatic, Congenital, Prosthetic, IV drugs, Degenerative, Devices
4. CATEGORIES OF IE
IE
├── 1. Native Valve Endocarditis
│ ├── Congenital heart disease
│ ├── Rheumatic heart disease
│ └── Degenerative heart disease
│
├── 2. Prosthetic Valve Endocarditis
│ (Early <60 days vs Late >60 days post-surgery)
│
├── 3. IE in IV Drug Abusers
│ (Often affects right-sided valves; S. aureus dominant)
│
└── 4. Health Care-Associated IE
(Catheters, dialysis, pacemakers)
5. CAUSATIVE ORGANISMS
🔴 Gram-Positive Bacteria (Most Common Overall)
| Organism | Clinical Setting | Type of IE |
|---|---|---|
| Viridans Streptococci (S. mutans, S. sanguinis) | Normal oral flora; dental procedures | Subacute IE |
| Enterococcus faecalis / faecium | GI/GU procedures, elderly | Subacute IE |
| S. bovis (S. gallolyticus) | Associated with colon cancer! | Subacute IE |
| S. aureus | Skin, IV drug users, healthcare | Acute IE - most aggressive |
| Coagulase-negative Staph (S. epidermidis) | Prosthetic valves | Subacute IE |
Memory tip for most common: "SSS EE" - Streptococci viridans, S. aureus, S. bovis, Enterococci, E. faecalis
🔵 Gram-Negative Bacteria: HACEK Group
| H | Haemophilus spp. (aphrophilus, paraphrophilus, influenzae, parainfluenzae) |
|---|---|
| A | Actinobacillus actinomycetemcomitans |
| C | Cardiobacterium hominis |
| E | Eikenella corrodens |
| K | Kingella kingae, K. denitrificans |
Key point: HACEK are oral commensals. They cause IE after dental procedures or poor oral hygiene. With modern automated blood culture systems, they usually grow within 2-3 days (historically were difficult to culture).
🔵 Non-HACEK Gram-Negatives (Rare)
- Salmonella, E. coli, Proteus mirabilis, Klebsiella, Pseudomonas aeruginosa (common in IV drug users)
🔬 Culture-Negative Endocarditis (CNE) - ~10% of cases
| Organism | Clue / Special Test |
|---|---|
| Coxiella burnetii (Q fever) | Anti-phase 1 IgG antibody titre > 1:800 (serology) |
| Bartonella spp. | Serology; often in homeless/cat exposure |
| Chlamydia psittaci | Serology; bird exposure |
| Brucella spp. | Repeat culture with special media |
| Legionella spp. | Serology / urine antigen |
| Tropheryma whipplei | PCR; causes Whipple's disease |
| Fungi (Candida, Aspergillus) | Blood culture + special fungal media |
Why is it culture-negative? Either: (1) prior antibiotics killed the bacteria before culture, or (2) the organism is inherently fastidious.
6. CLINICAL FEATURES - The "3-Source Model"
SOURCE 1 → LOCAL CARDIAC DAMAGE
- New or changed heart murmur (valve destruction)
- Heart failure (valve regurgitation)
- Myocardial abscess
- Valve rupture
SOURCE 2 → EMBOLIZATION (vegetation breaks off)
- Brain: stroke / mycotic aneurysm
- Kidneys: flank pain, hematuria
- Spleen: splenomegaly, infarcts
- Lungs (right-sided IE): septic pulmonary emboli
- Skin: Janeway lesions (non-tender, on palms/soles) ← emboli
- Eyes: emboli to retinal vessels
SOURCE 3 → IMMUNE COMPLEX DEPOSITION (body's immune response)
- Osler's nodes: TENDER nodules on finger/toe pads ← immune complexes
- Roth spots: retinal hemorrhages with pale center ← immune complexes
- Glomerulonephritis (immune complex deposition in kidney)
- Arthritis
CONSTANT BACTERAEMIA → Fever (most consistent symptom!)
Memory: Janeway vs Osler - "Janeway = Just emboli (painless), Osler = Ouch! (painful, immune)"
7. ACUTE vs SUBACUTE IE - Side-by-Side
| Feature | ACUTE IE | SUBACUTE IE (SABE) |
|---|---|---|
| Course | Fulminant (days to <6 weeks) | Insidious (6 weeks to months) |
| Fever | High fever | Low-grade fever, night sweats |
| Toxicity | Severe systemic toxicity | Vague systemic complaints (fatigue, weight loss) |
| WBC | Leucocytosis | Normal or mildly elevated |
| Prior valve disease | Not required | Usually present |
| Organisms | S. aureus, S. pneumoniae, S. pyogenes, N. gonorrhoeae | Viridans Streptococci, S. bovis, Enterococci, CoNS |
| Valve | Can attack normal valves | Usually abnormal/damaged valves |
Analogy: Acute IE is like a wildfire - fast, destroys everything. Subacute IE is like dry rot - slow, sneaky, but still destructive.
8. MODIFIED DUKE CRITERIA - Diagnosis
Purpose: Classify patients as Definite / Possible / Rejected IE
MAJOR Criteria (2 needed for definite IE)
- Blood culture positive for IE organisms (typical organisms in ≥2 separate cultures)
- Echocardiogram positive - showing vegetation, abscess, or new dehiscence of prosthetic valve; OR new valvular regurgitation
MINOR Criteria
- Predisposing heart condition or IV drug use
- Fever (≥38°C)
- Vascular phenomena (major arterial emboli, septic pulmonary infarcts, Janeway lesions, mycotic aneurysm, conjunctival hemorrhage)
- Immunologic phenomena (Osler's nodes, Roth spots, Rheumatoid factor, glomerulonephritis)
- Microbiologic evidence (positive blood culture that does not meet major criterion)
Scoring:
- DEFINITE IE = 2 major; OR 1 major + 3 minor; OR 5 minor
- POSSIBLE IE = 1 major + 1 minor; OR 3 minor
- Rejected = firm alternative diagnosis; or resolved with antibiotics in ≤4 days
9. LABORATORY DIAGNOSIS - Step by Step
Step 1: Blood Culture (MOST IMPORTANT TEST)
BLOOD CULTURE PROTOCOL:
├── Number: 3 sets is ideal (2 may be enough)
├── Timing: At hourly intervals, within 24 hours
│ (NOT less than 1 hour apart)
├── Volume: Adults = 10 ml (minimum 5 ml) per bottle
│ Children = 1-3 ml
├── Technique: Strict aseptic measures
│ Clean skin with 70% alcohol / povidone-iodine
│
├── When to take extra sets?
│ - If patient already on antibiotics
│ - If fastidious organisms are suspected
│
└── Why multiple cultures?
Bacteremia in IE is CONTINUOUS (not intermittent like in other infections)
→ No need to time with fever spikes
Step 2: Processing in Lab
- Culture on Blood Agar (BA) + MacConkey Agar
- Test isolates for Minimum Inhibitory Concentration (MIC) - especially for penicillin
- Monitor serum aminoglycoside levels to:
- Confirm adequate treatment
- Minimize toxicity
Step 3: If Culture Negative
- Prior antibiotics → Repeat cultures over several days without antibiotics
- Fastidious bacteria (e.g., Brucella) → Special culture media
- Obligate intracellular organisms (Coxiella, Chlamydia) → Serology
- Coxiella: Anti-phase 1 IgG > 1:800
Step 4: Other Specimens
- Culture of heart valves removed at surgery
- Culture of emboli removed at surgery
- Serology for Coxiella, Chlamydia psittaci, Brucella
10. PATHOLOGY - What Does It Look Like?
- Composition: thrombotic debris (fibrin + platelets) + microorganisms
- Located usually on the line of closure of the valve leaflet
- Appearance: Irregular, friable, shaggy masses
- Can destroy the valve leaflet, chordae tendineae, and underlying tissue
11. TREATMENT
Principles (BPPD)
- Bactericidal antibiotics only (bacteriostatics are insufficient - organisms are deep in avascular fibrin)
- Parenteral (IV) administration - ensures reliable blood levels
- Proper dosage - high doses to penetrate vegetations
- Duration: 4-6 weeks minimum
Empirical Treatment (when you can't wait for culture)
Take 3 blood cultures first, THEN start antibiotics!
- Penicillin-sensitive Streptococci (most common community-acquired)
- Enterococci
- Penicillinase-producing Staphylococci (MRSA coverage if healthcare-associated)
12. PREVENTION (Chemoprophylaxis)
High-Risk Patients Who Need Prophylaxis:
- Prosthetic heart valves
- Prior history of IE
- Congenital heart disease (unrepaired cyanotic CHD)
- Valvular heart disease
Procedures Requiring Prophylaxis (in high-risk patients):
- Dental procedures (manipulating gingiva/periapical region)
- Respiratory procedures
- GI/GU manipulation or surgery
- Open heart surgery
Important update: Guidelines now recommend prophylaxis only for the highest-risk patients undergoing only a few specific procedures - not for all patients with any heart condition.
QUICK SUMMARY FLOWCHART
BACTERAEMIA (dental/surgery/IV drugs)
↓
Bacteria adhere to damaged valve
↓
VEGETATION FORMS (fibrin + platelets + bugs)
↓
┌──────────────────┬────────────────────┐
↓ ↓ ↓
Local damage Embolism Immune Complexes
(murmur, CHF, (stroke, infarcts, (Osler's nodes,
abscess) Janeway lesions) Roth spots, GN)
↓
DIAGNOSIS: Blood culture + Echo (Duke Criteria)
↓
TREATMENT: IV Bactericidal antibiotics x 4-6 weeks
↓
PREVENTION: Prophylaxis in HIGH-RISK patients
MEMORY HOOKS AT A GLANCE
| Concept | Memory Aid |
|---|---|
| Organisms in native valve IE | "VS-E-SE": Viridans Strep, Enterococci, S. aureus, S. epidermidis |
| HACEK | "Have A Clean Eating Kitchen" |
| Culture-negative organisms | "Big Cats Bring Loud Trouble" - Bartonella, Coxiella, Brucella, Legionella, Tropheryma |
| Janeway vs Osler | Janeway = painless, palms/soles (embolism); Osler = painful, fingers (immune) |
| Acute vs Subacute organisms | Acute = S. aureus (the destroyer); Subacute = Viridans Strep (the sneak) |
| Blood culture rule | 3 sets, 1 hour apart, aseptic technique, adults 10 ml each |
| Treatment duration | 4-6 weeks IV bactericidal antibiotics |
Give newly modified duke criteria 2026
modified Duke criteria 2023 2024 2025 updated infective endocarditis new criteria
"Duke criteria" AND "infective endocarditis" AND diagnosis
https://pubrica.com/wp-content/uploads/2025/11/Clinical-Infe…
PMID: 37138445
Duke ISCVID 2023 criteria complete table minor criteria predisposing conditions imaging PET CT full list
https://pmc.ncbi.nlm.nih.gov/articles/PMC10681650
2023 Duke-ISCVID Criteria for Infective Endocarditis
(The Most Current Version - Published August 2023, Endorsed by 2023 ESC Guidelines)
Important clarification: There is no separate "2026" revision. The most current version is the 2023 Duke-ISCVID Criteria published in Clinical Infectious Diseases by Fowler et al. (PMID: 37138445). This replaced the Modified Duke Criteria (Li 2000) and is the current gold standard as of 2026. It is designed as a "Living Document" with periodic online updates.
OVERALL CLASSIFICATION - Unchanged Structure
| Classification | Criteria |
|---|---|
| DEFINITE IE | 2 Major; OR 1 Major + 3 Minor; OR 5 Minor (Clinical) OR Pathologic criteria |
| POSSIBLE IE | 1 Major + 1 Minor; OR 3 Minor |
| REJECTED IE | Firm alternative diagnosis; OR resolution with antibiotics ≤4 days; OR no pathologic evidence at surgery/autopsy after ≤4 days of antibiotics |
DEFINITE IE - Pathologic Criteria (Unchanged)
- Microorganisms identified in vegetation, embolic vegetation, or intracardiac abscess by culture, histology, PCR, amplicon/metagenomic sequencing, or in situ hybridization
New addition: Molecular identification methods (PCR, sequencing) are now formally included alongside culture
MAJOR CRITERIA
A. Microbiologic Major Criteria
(1) Positive Blood Cultures - UPDATED RULES
| Old Modified Duke (2000) | New Duke-ISCVID (2023) | |
|---|---|---|
| Typical organisms | 2 separate cultures, timed >12h apart | 2 or more separate blood culture sets - timing requirements removed |
| Nontypical organisms | Not specified separately | 3 or more separate blood culture sets |
| Venipuncture requirement | Separate venipunctures required | Separate venipuncture requirement removed |
- Viridans group Streptococci
- Streptococcus bovis / S. gallolyticus
- HACEK group
- Staphylococcus aureus
- Enterococcus faecalis (community-acquired, no primary focus) - NEW ADDITION
- Staphylococcus lugdunensis - NEW ADDITION
- Streptococcus pyogenes - NEW ADDITION
- Coagulase-negative Staphylococci
- Cutibacterium acnes
- Any other organism not listed above
(2) Positive Laboratory Tests - MAJOR NEW ADDITIONS
| Test | Organism | Criterion Level |
|---|---|---|
| PCR or nucleic acid-based technique | Coxiella burnetii, Bartonella spp., Tropheryma whipplei - from blood or tissue | MAJOR |
| Enzyme immunoassay (EIA) | Anti-phase 1 IgG for Coxiella burnetii titre > 1:800 | MAJOR |
| Amplicon or metagenomic sequencing | Coxiella, Bartonella, T. whipplei from blood/tissue | MAJOR |
| In situ hybridization | Any organism in appropriate tissue sample | MAJOR (pathologic) |
| PCR/sequencing for OTHER organisms | Any other organism from blood (not above 3) | MINOR only (pending more data) |
B. Imaging Major Criteria - MAJOR EXPANSION
| Modality | Findings for Major Criterion | Notes |
|---|---|---|
| Echocardiography (TTE/TEE) | Vegetation, abscess, pseudoaneurysm, intracardiac fistula, valvular perforation, new partial dehiscence of prosthetic valve | Unchanged; cornerstone; TEE preferred |
| Cardiac CT (NEW) | Paravalvular lesions (abscess, pseudoaneurysm, fistula), new partial dehiscence of prosthetic valve | Equivalent to echo; especially useful for prosthetic valves |
| [18F]FDG PET/CT (NEW) | Abnormal metabolic activity involving a native or prosthetic valve, ascending aortic graft (with valve involvement), intracardiac device leads, or other prosthetic material | Valid for prosthetic valve only if >3 months post-surgery; for CIEDs/leads at any time |
Why was PET/CT added? Echocardiography can miss IE on prosthetic valves (metal artifacts). PET/CT detects metabolic activity of infection even when echo is negative.
C. Surgical Major Criteria - BRAND NEW CATEGORY
- No Major Imaging Criterion is available, AND
- No subsequent histologic or microbiologic confirmation is available
Why added? Surgeons often directly see IE evidence during emergency surgery, before labs confirm it. This gives those findings formal diagnostic weight.
MINOR CRITERIA
A. Predisposing Conditions - EXPANDED
- Previous history of IE - NEWLY ADDED
- Prosthetic valve (any type)
- Previous valve repair
- Congenital heart disease
- More than mild regurgitation or stenosis of any etiology
- Endovascular CIED (Cardiac Implantable Electronic Device) - NEWLY ADDED (pacemakers, defibrillators)
- Transcatheter valve implant/repair (TAVI/TAVR) - NEWLY ADDED
- IV drug use
- Hypertrophic obstructive cardiomyopathy
B. Fever - UNCHANGED
- Temperature > 38°C (100.4°F)
C. Vascular Phenomena - EXPANDED
- Splenic abscess - NEWLY ADDED
- Cerebral abscess - NEWLY ADDED
D. Immunologic Phenomena - CLARIFIED
- Osler's nodes (tender subcutaneous nodules on finger/toe pads)
- Roth spots (retinal hemorrhages with pale center)
- Rheumatoid factor positivity
- Glomerulonephritis (with new specific definition added)
E. Microbiologic (Minor) - UPDATED
- Positive blood culture that does NOT meet Major Criterion
- NEW: Positive PCR or amplicon/metagenomic sequencing for organisms other than C. burnetii, Bartonella, or T. whipplei (those 3 = MAJOR; all others from blood = MINOR pending more data)
F. Imaging (Minor) - NEW MINOR
- [18F]FDG PET/CT showing abnormal activity around prosthetic valve when done within 3 months of cardiac surgery (too soon after surgery = minor, not major, due to normal post-op inflammation)
WHAT CHANGED vs THE OLD MODIFIED DUKE CRITERIA? - Summary Table
| Feature | Old Modified Duke (2000) | New Duke-ISCVID (2023) |
|---|---|---|
| Blood culture timing | Required 12h apart / 24h window | Timing removed |
| Separate venipuncture | Required | Removed |
| Typical organisms | Narrow list | Expanded (S. lugdunensis, E. faecalis, S. pyogenes added) |
| Prosthesis-specific organisms | Not recognized | New category: CoNS & C. acnes = typical only with prosthesis |
| Cardiac CT | Not recognized | New MAJOR imaging criterion |
| 18F-FDG PET/CT | Not recognized | New MAJOR (>3 months post-surgery) or Minor (<3 months) |
| Surgical evidence | Not recognized | New MAJOR criterion |
| PCR / Metagenomic sequencing | Not recognized | MAJOR for Coxiella/Bartonella/Whipplei; MINOR for others |
| Prior IE as predisposing | Not included | New MINOR predisposing condition |
| CIED/TAVI | Not included | New MINOR predisposing conditions |
| Splenic/cerebral abscess | Not included | New MINOR vascular phenomena |
| Fever | Minor criterion | Unchanged (though 2025 studies suggest removing it improves specificity) |
PERFORMANCE OF THE 2023 CRITERIA
- Sensitivity: 84.2% (vs 74% for old Modified Duke)
- Specificity: 93.9% (significantly better than 2023 ESC criteria which had 82.1%)
QUICK MEMORY AID FOR MAJOR CRITERIA (2023)
3 domains of MAJOR criteria:
M - MICROBIOLOGY (blood cultures + PCR/serology for Coxiella/Bartonella/Whipplei)
I - IMAGING (Echo + Cardiac CT + PET/CT >3 months post-op)
S - SURGERY (direct intraoperative inspection)
Bottom line for 2026 clinical practice: The 2023 Duke-ISCVID criteria are what you use today. The biggest practical changes are: (1) Cardiac CT and PET/CT are now formal major criteria - order them when echo is non-diagnostic, especially for prosthetic valves; (2) Molecular tests (PCR, metagenomic sequencing) now have formal diagnostic standing; (3) Blood culture timing rules are relaxed. The criteria are maintained as a living document by ISCVID.
make pdf 😅